Literature DB >> 15563005

Estimating bias in population parameters for some models for repeated measures ordinal data using NONMEM and NLMIXED.

Siv Jönsson1, Maria C Kjellsson, Mats O Karlsson.   

Abstract

The application of proportional odds models to ordered categorical data using the mixed-effects modeling approach has become more frequently reported within the pharmacokinetic/pharmacodynamic area during the last decade. The aim of this paper was to investigate the bias in parameter estimates, when models for ordered categorical data were estimated using methods employing different approximations of the likelihood integral; the Laplacian approximation in NONMEM (without and with the centering option) and NLMIXED, and the Gaussian quadrature approximations in NLMIXED. In particular, we have focused on situations with non-even distributions of the response categories and the impact of interpatient variability. This is a Monte Carlo simulation study where original data sets were derived from a known model and fixed study design. The simulated response was a four-category variable on the ordinal scale with categories 0, 1, 2 and 3. The model used for simulation was fitted to each data set for assessment of bias. Also, simulations of new data based on estimated population parameters were performed to evaluate the usefulness of the estimated model. For the conditions tested, Gaussian quadrature performed without appreciable bias in parameter estimates. However, markedly biased parameter estimates were obtained using the Laplacian estimation method without the centering option, in particular when distributions of observations between response categories were skewed and when the interpatient variability was moderate to large. Simulations under the model could not mimic the original data when bias was present, but resulted in overestimation of rare events. The bias was considerably reduced when the centering option in NONMEM was used. The cause for the biased estimates appears to be related to the conditioning on uninformative and uncertain empirical Bayes estimate of interindividual random effects during the estimation, in conjunction with the normality assumption.

Mesh:

Year:  2004        PMID: 15563005     DOI: 10.1023/b:jopa.0000042738.06821.61

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  17 in total

Review 1.  Modelling ordered categorical data: recent advances and future challenges.

Authors:  A Agresti
Journal:  Stat Med       Date:  1999 Sep 15-30       Impact factor: 2.373

Review 2.  Simulation of clinical trials.

Authors:  N H Holford; H C Kimko; J P Monteleone; C C Peck
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  Cumulative logit models for ordinal data: a case study involving allergic rhinitis severity scores.

Authors:  D J Lunn; J Wakefield; A Racine-Poon
Journal:  Stat Med       Date:  2001-08-15       Impact factor: 2.373

4.  Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.

Authors:  Catherijne A J Knibbe; Klaas P Zuideveld; Joost DeJongh; Paul F M Kuks; Leon P H J Aarts; Meindert Danhof
Journal:  Clin Pharmacol Ther       Date:  2002-12       Impact factor: 6.875

5.  The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.

Authors:  Maria C Kjellsson; Siv Jönsson; Mats O Karlsson
Journal:  AAPS J       Date:  2004-08-11       Impact factor: 4.009

6.  A random effects model for ordinal responses from a crossover trial.

Authors:  F Ezzet; J Whitehead
Journal:  Stat Med       Date:  1991-06       Impact factor: 2.373

7.  A population approach to initial dose selection.

Authors:  J Wakefield; S Walker
Journal:  Stat Med       Date:  1997-05-30       Impact factor: 2.373

8.  Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.

Authors:  S K Gupta; G Sathyan; E A Lindemulder; P L Ho; L B Sheiner; L Aarons
Journal:  Clin Pharmacol Ther       Date:  1999-06       Impact factor: 6.875

9.  Population pharmacodynamic model for ketorolac analgesia.

Authors:  J W Mandema; D R Stanski
Journal:  Clin Pharmacol Ther       Date:  1996-12       Impact factor: 6.875

10.  A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data.

Authors:  L B Sheiner
Journal:  Clin Pharmacol Ther       Date:  1994-09       Impact factor: 6.875

View more
  13 in total

1.  Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

Authors:  Elodie L Plan; Alan Maloney; France Mentré; Mats O Karlsson; Julie Bertrand
Journal:  AAPS J       Date:  2012-04-14       Impact factor: 4.009

2.  Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.

Authors:  Radojka M Savic; France Mentré; Marc Lavielle
Journal:  AAPS J       Date:  2010-11-11       Impact factor: 4.009

Review 3.  Population pharmacokinetics/pharmacodynamics of anesthetics.

Authors:  Erik Olofsen; Albert Dahan
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 4.  A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.

Authors:  Robert J Bauer; Serge Guzy; Chee Ng
Journal:  AAPS J       Date:  2007-03-02       Impact factor: 4.009

5.  The impact of misspecification of residual error or correlation structure on the type I error rate for covariate inclusion.

Authors:  Hanna E Silber; Maria C Kjellsson; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-02-14       Impact factor: 2.745

6.  Performance in population models for count data, part I: maximum likelihood approximations.

Authors:  Elodie L Plan; Alan Maloney; Iñaki F Trocóniz; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-04       Impact factor: 2.745

7.  Performance in population models for count data, part II: a new SAEM algorithm.

Authors:  Radojka Savic; Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-08-13       Impact factor: 2.745

8.  Sample size/power calculations for repeated ordinal measurements in population pharmacodynamic experiments.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-05       Impact factor: 2.745

9.  Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis.

Authors:  Roberto Bizzotto; Stefano Zamuner; Enrica Mezzalana; Giuseppe De Nicolao; Roberto Gomeni; Andrew C Hooker; Mats O Karlsson
Journal:  AAPS J       Date:  2011-06-21       Impact factor: 4.009

10.  Performance of three estimation methods in repeated time-to-event modeling.

Authors:  Kristin E Karlsson; Elodie L Plan; Mats O Karlsson
Journal:  AAPS J       Date:  2011-01-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.